RAC adopts four opinions on harmonised classification and labelling
Media enquiries: ECHA Press
The Committee for Risk Assessment (RAC) has adopted opinions on three proposals for harmonised classification and labelling (CLH) across Europe and an opinion following up a previous RAC opinion in relation to CLH.
Helsinki, 14 March 2011 - The opinions are as follows:
RAC agreed with the proposal from Germany to classify 4-tert-butylbenzoic acid as acutely toxic (by the oral route), as toxic to the central nervous system, liver, kidney, reproductive organs, hemopoietic1 system and thymus after repeated exposure, and as potentially damaging to fertility. The classification of this substance is not currently harmonised at EU level. 4-Tert-butylbenzoic acid is used as a stabiliser or an additive in polymers, or as a corrosion inhibitor.
RAC agreed with the proposal from the United Kingdom to classify metazachlor as a skin sensitiser, as a suspected carcinogen and as hazardous to the aquatic environment. The classification of this substance is not currently harmonised at EU level.
Metazachlor is used as a herbicide (on oil seed rape).
RAC agreed with the proposal from Germany to remove the classification of 2-ethoxyethanol as harmful when in contact with skin. RAC agreed to modify the current harmonised classification of 2-ethoxyethanol as harmful if inhaled, to toxic if inhaled. 2-Ethoxyethanol already has a harmonised classification as toxic for reproduction as it may damage fertility or the unborn child, as harmful if swallowed and for flammability (liquid and vapour). 2-Ethoxyethanol is a solvent used widely in commercial and industrial applications. It is used in products such as varnish removers and degreasing solutions.
Follow-up opinion on epoxiconazole under Article 77 (3) (c)
In its opinion on epoxiconazole of 17 March 2010, RAC was made aware of some planned studies that may be relevant for deciding on the appropriate harmonised classification of the substance as toxic for reproduction. RAC has reviewed the study plans and concluded that the proposed harmonised classification is unlikely to be modified by the results of the studies. The opinion was adopted following a request from the Executive Director of ECHA to RAC.
The role of RAC in EU regulatory processes
RAC is responsible for preparing scientific opinions of the Agency on proposals for harmonised classification and labelling and other questions relating to risks to human health or the environment. The final decision for harmonised classification and labelling will be taken by the European Commission through a committee procedure.
Upon specific requests from the Executive Director of ECHA, the Committee is responsible for drawing up opinions relating to risks to human health or the environment on any other aspects concerning the safety of substances on their own, in preparations or in articles (Article 77(3) (b) and (c) of REACH).
Further information about RAC is available on the ECHA website at the link below:
The opinions will be available in the near future at the following links: